Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...
The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...
The study evaluated thermal dynamics associated with CW-TSCPC and TLT using MicroPulse technology, such as temperature peak, ...
"SLT is a widely used first-line laser therapy for glaucoma but relies on a Q-switched Nd:YAG laser, which induces cellular ...
ViaLase announced the first patient was treated in a U.S. IDE clinical trial evaluating its femtosecond laser trabeculotomy ...
Iridex (IRIX) announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that retreatment of transscleral laser treatment using MicroPulse ...
Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...
More than 70 million people worldwide suffer from glaucoma. Treatment options have traditionally included eye drops to reduce the fluid the eye produces or surgery to unclog the eye's drainage. But a ...
ViaLase, a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40 million in additional finance. Based in Alisa Viejo, ...
Please provide your email address to receive an email when new articles are posted on . Frailty and older age are associated with significantly lower odds of undergoing surgery or laser treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results